Heights Capital Management’s ProQR Therapeutics PRQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.06M Sell
1,239,212
-1,523,218
-55% -$2.88M 0.42% 68
2026
Q2
$5.14M Buy
+2,762,430
New +$4.55M 1.19% 18

Other funds holding PRQR

Heights Capital Management's PRQR Position: Q3 2026 in Review

Heights Capital Management reduced its ProQR Therapeutics (PRQR) stake by 55% in Q3 2026, selling an estimated $2.88M and leaving 1,239,212 shares worth $2.06M. The position accounts for 0.42% of the portfolio, ranked #68.

Heights Capital Management first reported a position in PRQR in Q2 2026 and has held it in 2 quarters since. The position peaked at $5.14M in Q2 2026. 73 funds tracked by Wall St. Rank hold PRQR as of Q3 2026.

  • Heights Capital Management held 1,239,212 shares of ProQR Therapeutics worth $2.06M as of Q3 2026.
  • Heights Capital Management sold 1,523,218 ProQR Therapeutics shares in Q3 2026, an estimated $2.88M.
  • ProQR Therapeutics made up 0.42% of Heights Capital Management's portfolio in Q3 2026, its #68 holding.
  • Heights Capital Management first reported a position in ProQR Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Heights Capital Management's ProQR Therapeutics position peaked at $5.14M in Q2 2026.
  • 73 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2026.

Based on Heights Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.